In human studies, maqui extract (60–180 mg/day) improved insulin sensitivity, fasting glucose, and oxidative stress markers such as 8-iso-PGF2α, suggesting potential benefits in the early stages of CRS, before the establishment of irreversible structural damage [94]. This evidence concerns the gene INS and congenital rubella syndrome.